(Q37878482)

24 August 2017

1 reference

title

Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains (English)

1 reference

24 August 2017

1 reference

1 reference

poliovirus

1 reference

Pauline Verdijk

1

0 references

Nynke Rots

series ordinal

2

object named as

Nynke Y Rots

1 reference

24 August 2017

Wilfried A M Bakker

3

1 reference

24 August 2017

publication date

1 May 2011

1 reference

Expert Review of Vaccines

24 August 2017

published in

1 reference

24 August 2017

volume

10

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

635-644

1 reference

24 August 2017

cites work

Future of polio vaccines

1 reference

Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world

21 January 2018

1 reference

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

21 January 2018

1 reference

Implications of a circulating vaccine-derived poliovirus in Nigeria

21 January 2018

1 reference

Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy

21 January 2018

1 reference

Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication

21 January 2018

1 reference

New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis

21 January 2018

1 reference

The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox

21 January 2018

1 reference

Risk management in a polio-free world

21 January 2018

1 reference

Production of poliovirus vaccines: past, present, and future

21 January 2018

1 reference

Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.

21 January 2018

1 reference

Perspective: determinants of the severity of poliovirus outbreaks in the post eradication era.

21 January 2018

1 reference

Multivariate data analysis on historical IPV production data for better process understanding and future improvements

21 January 2018

1 reference

Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines.

21 January 2018

1 reference

Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains

21 January 2018

1 reference

Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants

21 January 2018

1 reference

Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba

21 January 2018

1 reference

Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells

21 January 2018

1 reference

IPV-Vero vaccine induces a strong booster reaction and is well tolerated in adults

21 January 2018

1 reference

Control of Influenza and Poliomyelitis with Killed Virus Vaccines

21 January 2018

1 reference

Polio immunity to killed vaccine: an 18-year follow-up

21 January 2018

1 reference

Immunity to poliomyelitis in The Netherlands

21 January 2018

1 reference

Poliomyelitis in the Netherlands: a review of population immunity and exposure between the epidemics in 1978 and 1992

21 January 2018

1 reference

Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses

21 January 2018

1 reference

Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine

21 January 2018

1 reference

Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infants

21 January 2018

1 reference

Serological response of infants to poliomyelitis vaccine

21 January 2018

1 reference

Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico

21 January 2018

1 reference

Immunologic memory induced at birth by immunization with inactivated polio vaccine in a reduced schedule.

21 January 2018

1 reference

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

21 January 2018

1 reference

Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence.

21 January 2018

1 reference

Immunobiology of HPV and HPV vaccines

21 January 2018

1 reference

Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons.

21 January 2018

1 reference

Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template

21 January 2018

1 reference

Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication

21 January 2018

1 reference

Engineering attenuated virus vaccines by controlling replication fidelity

21 January 2018

1 reference

A case for developing antiviral drugs against polio

21 January 2018

1 reference

Picornavirus non-structural proteins as targets for new anti-virals with broad activity

21 January 2018

1 reference

A global call for new polio vaccines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.51

1 reference

24 August 2017

1 reference